Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Facebook
Twitter
Pinterest
Telegram
Linkedin
WhatsApp
Artículos Relacionados
Comentarios
Deja un comentario
Todos los campos son requeridos
Ahora Reproduciendo
Sonido Cubano
A Continuación
- Desde Mi Habana
- Cartas a la Redacción
- Cancionero Iberoamericano
Más Vistas
- Cadena canadiense consolida en Cuba nueva marca Resonance Hotels
- Colombia: Aerolínea Avianca reanudó vuelos a Cuba (+Foto)
- Palabras al viento en estreno mundial
- Nada impedirá el Festival de Cine de La Habana
- Presidente Díaz-Canel lamenta fallecimiento del revolucionario cubano Julio Camacho Aguilera (+Post)
